Tirzepatide is the next-generation “dual-action” weight loss injection, offering even more potent results than Semaglutide. By targeting two hunger-regulating hormone receptors, it helps patients break through plateaus and achieve profound weight reduction, often exceeding 20%.
What is Tirzepatide?
Tirzepatide (the active ingredient in Mounjaro®/Zepbound™) is the first and only unimolecular dual GIP and GLP-1 receptor agonist. While Semaglutide targets one hormone, Tirzepatide targets two.
This advanced mechanism makes it the most effective medical weight loss option currently available, suitable for patients who have a significant amount of weight to lose or who did not respond fully to other treatments.